OC
EXAS

Oarsman Capital’s Exact Sciences EXAS Stock Holding History

Oarsman Capital’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,000
Closed -$56.2K – 442
2024
Q4 		$56.2K Hold
1,000
– – 0.01% 415
2024
Q3 		$68.1K Buy
+1,000
New +$56.4K 0.01% 399
2021
Q3 		– Sell
-1,643
Closed -$204K – 197
2021
Q2 		$204K Sell
1,643
-57
-3% -$6.8K 0.08% 181
2021
Q1 		$224K Buy
1,700
+48
+3% +$6.57K 0.1% 167
2020
Q4 		$219K Buy
+1,652
New +$200K 0.09% 167

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oarsman Capital's EXAS Position: Q1 2025 in Review

Oarsman Capital sold out of Exact Sciences (EXAS) in Q1 2025, closing a stake of 1,000 shares — an estimated $56.2K sold.

Oarsman Capital first reported a position in EXAS in Q4 2020 and held it in 5 quarters. The position peaked at $224K in Q1 2021. 557 funds tracked by Wall St. Rank hold EXAS as of Q1 2025.

  • Oarsman Capital reported no remaining Exact Sciences position as of Q1 2025 after selling out during the quarter.
  • Oarsman Capital sold 1,000 Exact Sciences shares in Q1 2025, an estimated $56.2K.
  • Oarsman Capital first reported a position in Exact Sciences in Q4 2020 and held it in 5 quarters.
  • Oarsman Capital's Exact Sciences position peaked at $224K in Q1 2021.
  • 557 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2025.

Based on Oarsman Capital's 13F filing for Q1 2025, filed 14 May 2025.